Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 June 2019 | Story Valentino Ndaba | Photo Albert van Biljon
Alison Botha
Over and above being a survivor, Alison Botha is an inspiration.

It was an ordinary December 1994 evening in Port Elizabeth. Alison Botha parked her car in front of her home. A man ambushed her at knife point. Minutes later, she was forced into the passenger seat and the perpetrator drove off, picking his friend up on their way to the coastal bushes of the city.
 
What was supposed to be an ordinary evening turned into a horrific experience which changed Botha’s life forever. She was raped, strangled, had her throat slit and her stomach cut open. Physicians called her survival a medical miracle. The true miracle though, is how she has chosen to deal with the experience. 

Botha overcame her fear of public speaking and has become an international motivational speaker who also authored a first-person account of her ordeal and recovery in 1998, titled I Have Life.

Aluta continua against gender-based violence

As part of our university’s advocacy against gender-based violence, the Human Resources’ Division for Organisational Development and Employee Wellness hosted Botha for a motivational talk on 5 June 2019 at the Bloemfontein Campus. In telling her story, Botha stated that she still receives healing.

While welcoming guests and the speaker, Prof Prakash Naidoo, Vice-Rector: Operations touched on Project Caring which is supported by the Rectorate. “We care for you and part of that caring agenda is gender-based violence. We encourage you to speak out about this issue, don’t remain silent, someone will listen,” he advised.

From victim to victor

Botha believes that if her story serves to help someone else avoid the same situation or perhaps even survive a similar trauma, then she has served her purpose. “I now believe that the evil is far outweighed by all the good that has come out of my choice to share my story,” she said.

Much of the reason behind her strength lies in what she terms her own ABC principle which speaks to attitude, belief and choice. “We are not always going to be in control of everything that happens to us. But we always control how we respond,” said Botha. 

The story of Botha’s survival, recovery and victory proves that the human spirit cannot be crushed. There is indeed life after a near-death tragedy.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept